- Home
- CPHI vs CWD Comparison
CPHI vs CWD Comparison
Compare CPHI & CWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPHI
- CWD
- Stock Information
- Founded
- CPHI N/A
- CWD 2009
- Country
- CPHI China
- CWD United States
- Employees
- CPHI N/A
- CWD N/A
- Industry
- CPHI Biotechnology: Pharmaceutical Preparations
- CWD Real Estate
- Sector
- CPHI Health Care
- CWD Finance
- Exchange
- CPHI Nasdaq
- CWD Nasdaq
- Market Cap
- CPHI 4.7M
- CWD 4.5M
- IPO Year
- CPHI N/A
- CWD 2023
- Fundamental
- Price
- CPHI $1.95
- CWD $4.25
- Analyst Decision
- CPHI
- CWD
- Analyst Count
- CPHI 0
- CWD 0
- Target Price
- CPHI N/A
- CWD N/A
- AVG Volume (30 Days)
- CPHI 26.1K
- CWD 3.7M
- Earning Date
- CPHI 11-12-2025
- CWD 11-11-2025
- Dividend Yield
- CPHI N/A
- CWD N/A
- EPS Growth
- CPHI N/A
- CWD N/A
- EPS
- CPHI N/A
- CWD N/A
- Revenue
- CPHI $4,396,201.00
- CWD $32,323,000.00
- Revenue This Year
- CPHI N/A
- CWD N/A
- Revenue Next Year
- CPHI N/A
- CWD $56.47
- P/E Ratio
- CPHI N/A
- CWD N/A
- Revenue Growth
- CPHI N/A
- CWD N/A
- 52 Week Low
- CPHI $1.20
- CWD $1.63
- 52 Week High
- CPHI $3.35
- CWD $48.00
- Technical
- Relative Strength Index (RSI)
- CPHI 60.72
- CWD 43.25
- Support Level
- CPHI $1.85
- CWD $4.38
- Resistance Level
- CPHI $1.97
- CWD $4.97
- Average True Range (ATR)
- CPHI 0.11
- CWD 0.48
- MACD
- CPHI -0.01
- CWD -0.34
- Stochastic Oscillator
- CPHI 78.00
- CWD 1.01
About CPHI China Pharma Holdings Inc.
China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection and others.
About CWD CaliberCos Inc.
CaliberCos Inc is an asset management firm whose primary goal is to enhance the wealth of investors seeking to make investments in middle-market assets. The company's funds include investment vehicles focused on real estate, private equity, and debt facilities. The company earns asset management fees calculated as a percentage of managed capital in funds and offerings. The company markets services through direct sales to private investors, wholesaling to investment advisers, direct sales to family offices and institutions and through in-house client services. The company operates into three reportable segments: Fund Management, Development, and Brokerage. The majority of revenue is derived from the fund management fees segment.